| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
112.96(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $90.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leavitt Michael O |
Director |
• • – |
2020-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,737 |
20,243 |
|
- |
|
| Anderson Richard H |
Director |
• • – |
2020-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,737 |
97,274 |
|
- |
|
| Oleary Denise M |
Director |
• • – |
2020-04-03 |
4 |
D |
$86.27 |
$80,145 |
D/D |
(929) |
65,615 |
|
- |
|
| Oleary Denise M |
Director |
• • – |
2020-04-03 |
4 |
OE |
$44.13 |
$80,008 |
D/D |
1,813 |
66,544 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2020-02-20 |
4 |
B |
$113.68 |
$997,087 |
D/D |
8,771 |
605,190 |
2.81 |
-19% |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2019-12-24 |
4 |
S |
$113.56 |
$5,776,101 |
D/D |
(50,856) |
71,013 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2019-12-24 |
4 |
OE |
$41.60 |
$2,333,054 |
D/D |
42,770 |
109,571 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2019-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,275 |
50,802 |
|
- |
|
| Anderson Richard H |
Director |
• • – |
2019-12-06 |
4 |
B |
$113.29 |
$566,450 |
D/D |
5,000 |
95,231 |
2.39 |
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2019-12-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
18,182 |
18,182 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2019-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,182 |
594,425 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2019-12-02 |
4 |
AS |
$110.28 |
$5,770,829 |
D/D |
(52,166) |
52,068 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2019-12-02 |
4 |
OE |
$47.00 |
$3,195,798 |
D/D |
52,166 |
104,234 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2019-11-15 |
4 |
AS |
$110.59 |
$4,102,092 |
D/D |
(36,874) |
188,262 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2019-11-15 |
4 |
OE |
$38.81 |
$1,431,080 |
D/D |
36,874 |
225,136 |
|
- |
|
| Wall Brett A. |
EVP & Group Pres Restora Thera |
• – – |
2019-11-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
13,175 |
|
- |
|
| Wall Brett A. |
EVP & Group Pres Restora Thera |
• – – |
2019-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,075 |
|
- |
|
| Salmon Sean |
EVP & Group President Diabetes |
• – – |
2019-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,409 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2019-11-01 |
4 |
AS |
$109.11 |
$5,702,995 |
D/D |
(52,165) |
52,068 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2019-11-01 |
4 |
OE |
$29.52 |
$1,895,478 |
D/D |
52,165 |
57,381 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2019-11-01 |
4 |
AS |
$109.50 |
$4,267,872 |
D/D |
(38,976) |
188,262 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2019-11-01 |
4 |
OE |
$38.81 |
$1,516,012 |
D/D |
38,976 |
189,464 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2019-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,729 |
61,536 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2019-10-11 |
4 |
D |
$107.58 |
$7,836,988 |
D/D |
(72,848) |
49,072 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2019-10-11 |
4 |
OE |
$62.76 |
$6,808,395 |
D/D |
84,207 |
121,920 |
|
- |
|
680 Records found
|
|
Page 12 of 28 |
|
|
0.78 (0.93%) 
